Product correctly added to cart.

discount label
CP-547632
View 3D

Targetmol logo

CP-547632

CAS: 252003-65-9

Ref. TM-T10870L

1mg
42.00 €
5mg
91.00 €
10mg
128.00 €
25mg
254.00 €
50mg
493.00 €
100mg
714.00 €
1ml*10 (DMSO)
95.00 €
Estimated delivery in United States, on Friday 12 Apr 2024

Product Information

Name:
CP-547632
Synonyms:
  • CP547632
  • Cp-547632
  • 3-[(4-Bromo-2,6-Difluorobenzyl)Oxy]-5-[3-[4-(Pyrrolidin-1-Yl)Butyl]Ureido]Isothiazole-4-Carboxamide
Description:

CP-547632 is an orally available and potent, ATP-competitive dual inhibitor of VEGFR-2 and FGF kinase F with IC50s of 11 nM and 9 nM, respectively. CP-547632 is selective, with higher selectivity for VEGFR2 and bFGF than for EGFR, PDGFRβ and related tyrosine kinases (TKs). PDGFRβ and related tyrosine kinases (TKs) CP-547632 has antitumour activity.

Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
532.4
Formula:
C20H24BrF2N5O3S
Purity:
98.51%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T10870L CP-547632

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!Please accept the use of cookies to have a better experience on our website.

Cookies are important for you, they influence your browsing experience, they help us to protect your privacy and allow us to proceed with the requests that you demand through this website. We use our own and third-party cookies to analyze our services. If you consent to its installation, click on "Accept", otherwise click on "Reject". You can also set your preferences by clicking "Settings". More information is available in our Cookies Policy.